Navigation Links
Neurobiological Technologies Reports Going Concern Qualification
Date:9/19/2007

EMERYVILLE, Calif., Sept. 19 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. announced today that its financial statements for the fiscal year ended June 30, 2007, included in the Company's Annual Report on Form 10-K filed on September 13, 2007, contain a going concern qualification from its independent accounting firm, Odenberg, Ullakko, Muranishi & Co. LLP.

As of June 30, 2007, the Company had cash and cash equivalents and short term investments of approximately $8.9 million. The Company recently filed a registration statement on Form S-1 to raise $65 million in an underwritten common stock offering, which is expected to close in October 2007.

This announcement is being made in compliance with Nasdaq Marketplace Rule 4350(b)(1)(B), which requires separate disclosure of receipt of an audit opinion that contains a going concern qualification. This announcement does not represent any change or amendment to the Company's 2007 financial statements or to its Annual Report on Form 10-K.

About Neurobiological Technologies, Inc.

Neurobiological Technologies, Inc. ("NTI") is a specialty biopharmaceutical company with expertise in identifying and acquiring promising drug candidates and in designing and managing late-stage clinical trials for central nervous system conditions. NTI is currently developing Viprinex, a novel reperfusion agent that is in pivotal Phase 3 trials for the treatment of acute ischemic stroke.

Forward-Looking Statements

This press release may contain forward-looking statements. These statements relate to future events and are subject to risks, uncertainties and assumptions about the Company. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. Actual events or results may differ materially. Many factors may cause our actual results to differ materially from any forward-looking statement, including the factors detailed in our filings with the Securities and Exchange Commission and Canadian securities regulatory authorities, including but not limited to our Forms 10-K and 10-Q. We do not undertake to update any forward-looking statements.


'/>"/>
SOURCE Neurobiological Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Researchers Develop Technologies to Devour Food Pathogens
2. Researchers Study Safety of Assisted Reproductive Technologies
3. India to Propose Global Fund for Clean Energy Technologies
4. Autopsy reports could be valuable and informative
5. China reports declining number of SARS Cases
6. Russia Reports First SARS Case
7. Research reports that c-section deliveries are rising
8. Jharkhand reports 13,000 Malaria cases
9. Uganda Reports Failure To Contain Sleeping Sickness
10. WHO reports 36 million deaths world wide due to chronic diseases
11. Reports of Hantavirus infection in India raise concerns
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... , ... “Engineering Bubbles,” an oil painting submitted by Canadian radiology resident Dr. ... at the Annual Meeting in Los Angeles. The first annual art forum was a ... Meeting attendees. , “Through art I hope to educate people about radiology and ...
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... Over $60 ... year’s best in pet gear and toys, leading product review site for Toys, Tots, ... of Excellence Awards at their Spring Showcase at the Metropolitan Pavilion in New ...
(Date:5/2/2016)... , ... May 02, 2016 , ... ... has announced a new Specialty Pharmacy Patient Satisfaction Award that will recognize specialty ... the quarterly results from Zitter Health Insights’ Specialty Pharmacy Patient Satisfaction Survey compiled ...
(Date:5/2/2016)... ... , ... According to an American Psychological Association article, the Centers ... the age of 18. Of those who survive, many still face effects as they ... In her new book, Lyah! Lyah! Pants on Fyah!, she shares stories from women ...
(Date:5/2/2016)... ... 2016 , ... Consultative health care market research firm ... Duane Reed, VP of business development of AJMC Strategic Solutions, will be session ... General Meeting from May 15-17 at the Boca Raton Resort & Club ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... , May 2, 2016  Deerfield announced ... financing of Graybug Vision, Inc. Graybug Vision is ... therapies that may transform care for ocular diseases ... Graybug Vision,s technology was first developed at Johns ... a startup venture. Graybug Vision ...
(Date:4/29/2016)... April 29, 2016  In the next ten ... shift from systems dependent on CRTs monitors to those ... modality CRT Medical monitors and will automatically sync ... host of foreseeable benefits to this technological advancement, ... modalities have to be replaced in order to ...
(Date:4/29/2016)... , April 29, 2016 ... glyco-biology expertise, today announces the appointment of Dr. ... Dr. Zurlo is an oncologist with many years clinical ... and biotechnology industries. His last role was at Mologen ... of the Executive Board. Previously Dr. Zurlo held various ...
Breaking Medicine Technology: